(Q33339873)

25 July 2017

A phase II study of STEALTH cisplatin (SPI-77) in patients with advanced non-small cell lung cancer (English)

1 reference

25 July 2017

1 reference

1 reference

9

Herbst RS

1 reference

25 July 2017

Kim ES

1

1 reference

25 July 2017

Lu C

2

1 reference

25 July 2017

Khuri FR

3

1 reference

25 July 2017

Tonda M

4

1 reference

25 July 2017

Glisson BS

5

1 reference

25 July 2017

Liu D

6

1 reference

25 July 2017

Jung M

7

1 reference

25 July 2017

Hong WK

8

1 reference

25 July 2017

1 December 2001

1 reference

25 July 2017

1 reference

25 July 2017

34

1 reference

25 July 2017

3

1 reference

25 July 2017

427-432

1 reference

Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer

25 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900278-1

7 January 2021

Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900278-1

7 January 2021

Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900278-1

7 January 2021

Carboplatin. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900278-1

7 January 2021

Clinical Pharmacokinetics of Carboplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900278-1

7 January 2021

Light microscopic localization of silver-enhanced liposome-entrapped colloidal gold in mouse tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900278-1

7 January 2021

A phase I study of STEALTH cisplatin (SPI-77) and vinorelbine in patients with advanced non small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900278-1

7 January 2021

Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900278-1

7 January 2021

Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900278-1

7 January 2021

10.1016/S0169-5002(01)00278-1

Identifiers

DOI

1 reference

25 July 2017

1 reference